Medicaid AMPs May Include More PBM Discounts, If CMS Can Figure Out How
Executive Summary
CMS wants to include a broader array of pharmacy benefit manager price concessions in calculating Medicaid average manufacturer prices for reimbursing outpatient prescription drugs
You may also be interested in...
340B Drug Price Transparency Gains Traction
A Web site created through a pilot program has helped instill greater confidence among 340B entities on the accuracy of the drug prices they pay, and a bill pending in Congress would ensure price transparency
340B Drug Price Transparency Gains Traction
A Web site created through a pilot program has helped instill greater confidence among 340B entities on the accuracy of the drug prices they pay, and a bill pending in Congress would ensure price transparency
Medicaid AMPs Exclude PBM Discounts Outside Of Mail Order – Final Rules
CMS has been persuaded to exclude pharmacy benefit manager price concessions, other than mail-order, from Medicaid AMPs, because PBMs do not take possession of drug products in most cases nor are their financial transactions easily tracked by manufacturers